Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tivic Health Systems, Inc. - Common stock (NQ:TIVC)

3.805 +0.055 (+1.47%)
Streaming Delayed Price Updated: 1:17 PM EDT, Jun 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Tivic Health Systems, Inc. - Common stock

< Previous 1 2 3 4 Next >
Tivic Health Completes Optimization Study for Its Non-Invasive Vagus Nerve Stimulation Device
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health Announces 2025 Annual Meeting of Stockholders
From Tivic Health Systems, Inc.
Via Business Wire
Sidoti Events, LLC's Virtual May Micro-Cap Conference
Via ACCESS Newswire
Life Sciences Investor Forum: Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Tivic Reports First Quarter 2025 Financial Results and Provides Updates on Business Transformation
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health Enters GMP Manufacturing Validation Agreement with Scorpius BioManufacturing in Preparation for FDA Submission
From Tivic Health Systems, Inc.
Via Business Wire
Life Sciences Investor Forum Agenda Announced for June 11th-12th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Tivic Expands VNS Intellectual Property Portfolio
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health to Report First Quarter 2025 Financial Results on May 15th Via Conference Call and Webcast
From Tivic Health Systems, Inc.
Via Business Wire
SmallCaps Gaining Momentum: TIVC, GELS, SLI, OBIO in Healthcare, Biotech, Energy, Military Defense, Etc. – More Stocks Inside
Via AB Newswire
Topics Government
Tivic Health Reports White House Briefing and FDA Meetings Secured Positive Interest in Potential Military and Defense Applications of Its Product Candidates
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health Extends its Worldwide License of TLR5 Agonist Entolimod to Include the Treatment of Neutropenia
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health Systems, Inc. Regains Compliance with NASDAQ Minimum Bid Price Listing Rule
From Tivic Health Systems, Inc.
Via Business Wire
$2 Stocks to Watch: PNPN.V, TIVC, APVO, OSRH, PRSO Biotech Breakthroughs, MedTech Momentum Metallic Metals Power Play & Signal Innovation
Via AB Newswire
Topics Intellectual Property
Tivic Reports Year End 2024 Financial Results and Provides Overview of Strategy for Transformation and Growth
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health to Report 2024 Year-End Financial Results on March 21st Via Conference Call and Webcast
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health and Feinstein Institute Present New Data Showing Personalized Vagus Nerve Stimulation Method Optimizes Impact on Autonomic Nervous System
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health Systems, Inc. Announces Reverse Stock Split
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health Names Biotech Industry Veteran Michael K. Handley to Executive Leadership Team
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health Acquires Exclusive Worldwide Rights to Phase III TLR5 Agonist from Statera Biopharma
From Tivic Health Systems, Inc.
Via Business Wire
CEO Letter to Shareholders Issued by Tivic Health
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Reports Third Quarter 2024 Financial Results and Provides Business Update
From Tivic Health Systems, Inc.
Via Business Wire
Enrollment Complete in Tivic Health Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health Validates European Patents in Great Britain, Germany, and France
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health Systems, Inc. to Report Third Quarter 2024 Financial Results on November 14
From Tivic Health Systems, Inc.
Via Business Wire
First Subject Enrolled in Tivic Health’s Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health CEO Jennifer Ernst to Present at New York BioFuture 2024
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health Receives Approval from Institutional Review Board for ncVNS Optimization Study, Readies for Enrollment
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health Accelerates VNS Commercial Strategy Development
From Tivic Health® Systems, Inc.
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.